Location History:
- Skovvej, DK (1983)
- Vedbaek, DK (1983 - 1992)
Company Filing History:
3 out of 103 
1 out of 1 
1 out of 1,777 
Years Active: 1983-1992
Title: Inventor Spotlight: Karin D Jorgensen
Introduction
Karin D Jorgensen, a distinguished inventor based in Vedbaek, Denmark, has made significant contributions to the medical field, particularly in the use of human growth hormone for treating intoxication. With a total of five patents to her name, Jorgensen's innovations are paving the way for new therapeutic approaches in critical healthcare scenarios.
Latest Patents
Among her most recent patents are formulations of human growth hormone designed for unit dose applications. These unit dose preparations provide a pharmacologically active dose of human growth hormone to effectively treat individuals suffering from intoxication due to substances metabolized by the liver's microsomal enzymes, such as hexobarbiturates and alcohol. Her research and developments in this area highlight the potential of human growth hormone as a viable treatment option for those affected by acute poisoning.
Career Highlights
Karin has held influential roles at renowned companies such as Novo Industri A/S and Nordiske Gentofte A/S. Her work in these organizations has contributed immensely to the advancement of medical treatments, establishing her as a key player in the biomedical sector. With her innovative mindset and dedication, she continues to drive advancements in healthcare.
Collaborations
Throughout her career, Karin has collaborated with esteemed professionals like Lars Thim and Alister J Moody. These partnerships have not only enhanced her research endeavors but have also facilitated the exchange of knowledge and expertise, further contributing to the development of her patent portfolio.
Conclusion
Karin D Jorgensen is a testament to the impact that dedicated inventors have on medical advancements. Her innovative contributions in the area of human growth hormone treatment for intoxication mark a significant stride forward in healthcare solutions. As she continues her work, her influence is expected to grow, further enhancing patient care and safety in the face of toxicological emergencies.